OpenVSafe by OpenVAERS
Search V-safe

VE6-23630-47045

2 vaccinations 5 coded responses 16 check-ins 5 free-text entries 3 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
191 / PA
Registered
2020-12-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-18
    Registered in v-safe
  2. 2020-12-18
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-18
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-09
    Dose 2 — Pfizer-BioNTech
  9. 2021-01-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cough — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Dry cough
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-01-10
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  11. 2021-01-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary pain, Hyperhidrosis, Tenderness — Feeling: Fair · Site: Pain · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Pain, tenderness under L axilla, R neck, L neck, diaphoresis
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-12
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Get care from a doctor or other healthcare professional
    1 call case(s)
  13. 2021-01-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Tenderness — Feeling: Good
    Free text: Mild tenderness under L axilla
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-16
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-23
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-01-30
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-13
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-25
  20. 2021-04-10
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-07-10
    Survey response — 6 months, dose 2
    MedDRA: Hepatic enzyme increased — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Elevated liver enzymes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-07-10
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  23. 2021-07-14
  24. 2022-01-09
    Survey response — 12 months, dose 2
    MedDRA: Pregnancy — Feeling: Good · Be unable to work or attend school
    Free text: Pregnancy
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-18Pfizer-BioNTech
22021-01-09Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-01-10 Unsuccessful
2021-01-12 Unsuccessful
2021-07-10 Unsuccessful

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-10

Systemic reaction (other): Dry cough

2021-01-12

Systemic reaction (other): Pain, tenderness under L axilla, R neck, L neck, diaphoresis

2021-01-14

Systemic reaction (other): Mild tenderness under L axilla

Release 9 — 6 months, dose 2

2021-07-10

Symptoms: Elevated liver enzymes

Release 10 — 12 months, dose 2

2022-01-09

Symptoms: Pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHepatic enzyme increased ✓ ✓ ✓
SDPregnancy · · ✓
SROAxillary pain ✓ ✓ ✓
SROCough ✓ ✓ ✓
SROHyperhidrosis ✓ ✓ ✓
SROLymph node pain ○ ○ ○
SRONeck pain ○ ○ ○
SROTenderness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release